id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-D-4437-0001,FDA,FDA-2016-D-4437,"In-Use Stability Studies and Associated Labeling Statements for
Multiple-Dose Injectable Animal Drug Products; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2017-01-04T05:00:00Z,2017,1,2017-01-04T05:00:00Z,,2017-01-04T14:16:51Z,2016-31855,0,0,0900006482448bfe
FDA-2016-D-4437-0002,FDA,FDA-2016-D-4437,Guidance for Industry; In-Use Stability Studies and Associated Labeling Statements for Multiple-Dose Injectable Animal Drug Products; Draft Guidance #242,Other,Guidance,2017-01-04T05:00:00Z,2017,1,2017-01-04T05:00:00Z,2017-03-07T04:59:59Z,2024-11-07T23:52:13Z,,1,0,09000064824499c9